Articles from DJS Law Group

The DJS Law Group announces that it is investigating claims on behalf of investors of Neumora Therapeutics, Inc. (“Neumora” or “the Company”) (NASDAQNMRA) for violations of the securities laws.

The DJS Law Group reminds investors of a class action lawsuit against PDD Holdings, Inc. (“PDD” or “the Company”) (NASDAQPDD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The DJS Law Group reminds investors of a class action lawsuit against Global Cord Blood Corporation (“Global Cord” or “the Company”) (OTC: CORBF) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The DJS Law Group reminds investors of a class action lawsuit against Lincoln National Corporation (“Lincoln National” or “the Company”) (NYSELNC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The DJS Law Group reminds investors of a class action lawsuit against Compass Minerals International, Inc. (“Compass Minerals” or “the Company”) (NYSECMP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The DJS Law Group reminds investors of a class action lawsuit against Autodesk, Inc. (“Autodesk” or “the Company”) (NASDAQADSK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The DJS Law Group reminds investors of a class action lawsuit against GoodRx Holdings, Inc. (“GoodRx” or “the Company”) (NASDAQGDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.